Amneal Announces FDA Approval and Launch of Lanreotide Injection
Go back to Amneal Announces FDA Approval and Launch of Lanreotide Injection| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 19.33 -0.17 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.50 | 52 Week High | $0.19 | |||
| Open | $19.70 | 52 Week Low | $0.07 | |||
| Day High | $20.17 | P/E | N/A | |||
| Day Low | $18.74 | EPS | $-0.01 | |||
| Volume | 3,575,395 | |||||
